Industry Connect with CSL

UQ researchers will have the opportunity to join an online information session early in February 2022 to hear
Dr Marthe D’Ombrain of CSL launch their 2022 Research Acceleration Initiative.

CSL’s Research Acceleration Initiative aims to fast-track discovery of antibody, cell and gene therapies through partnerships between CSL and UQ, and other Australian and global research organisations.

Applications open 4 January 2022. Successful applicants will receive up to $250,000 per year for up to 2 years (max $500,000 funding) to accelerate translation of their research.

The Initiative will focus on target validation and drug discovery projects in CSL’s therapeutic areas, specifically immunology, hematology, respiratory, cardiovascular and metabolic diseases and organ transplant.

Therapeutic areas

Cardiovascular and Metabolic

Next steps

Visit this page again for dates on webinar information sessions scheduled for early February 2022.

Online information session details


Times to be confirmed


Dates to be confirmed

Online session links

To register your interest to receive dates for online information session links please email

Contact us

Contact us for more information about this and other Industry Connect events.

Contact us